Pharma

Your Article Summary

See Latest Articles

Adolor Corporation Reports Second Quarter 2009 Financial Results
Adolor Corporation, 07/30/09

Adolor Corporation reported net product sales of ENTEREG for the three and six months ended June 2009 of approximately $2.4 million and $3.8 million, respectively, on total net shipments of approximately $2.9 million and $4.9 million, respectively. Under Adolor’s current revenue recognition policy, revenue related to a customer shipment is deferred until subsequent re–orders by that customer. As of June 2009, there were approximately 450 repeat–order hospitals for ENTEREG, up from 300 at March 2009.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09

Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09

 See all of Financial Reports